1 |
K. M. Burbach, A. Poland & C. A. Bradfield. (1992). Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proceedings of the National Academy of Sciences, 89(17), 8185-8189.
DOI
|
2 |
C. Ma, J. L. Marlowe & A. Puga. (2009). The aryl hydrocarbon receptor at the crossroads of multiple signaling pathways. EXS, 99, 231-257.
|
3 |
E. J. Choi, D. G. Toscano, J. A. Ryan, N. Riedel & W. A. Toscano Jr. (1991). Dioxin induces transforming growth factor-alpha in human keratinocytes. The Journal of Biological Chemistry, 266(15), 9591-9597.
DOI
|
4 |
A. Levine-Fridman, L. Chen & C. J. Elferink. (2004). Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. Molecular Pharmacology, 65(2), 461-469.
DOI
|
5 |
F. Yang & D. Bleich. (2004). Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells. Journal of Biological Chemistry, 279(34), 35403-35411.
DOI
|
6 |
J. Guo et al. (2004). Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. Toxicology and Applied Pharmacology, 194(1), 79-89.
DOI
|
7 |
B. D. Abbott, G. H. Perdew & L. S. Birnbaum. (1989). Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicology and Applied Pharmacology, 126(1), 16-25.
DOI
|
8 |
E. A. Thackaberry, E. J. Bedrick, M. B. Goens, L. Danielson, A. K. Lund, D. Gabaldon, S. M. Smith & M. K. Walker. (2003). Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicological Sciences, 76(2), 407-417.
DOI
|
9 |
P. Fernandez-Salguero et al. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science, 268(5211), 722-726.
DOI
|
10 |
A. B. Okey, D. S. Riddick & P. A. Harper. (1994). Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends in Pharmacological Sciences, 15(7), 226-232.
DOI
|
11 |
Y. F. Lu, M. Santostefano, B. D. Cunningham, M. D. Threadgill & S. Safe. (1996). Substituted flavones as aryl hydrocarbon receptor agonists and antagonists. Biochemical Pharmacology, 51(8), 1077-1087.
DOI
|
12 |
J. E. Lee & S. Safe. (2000). 3',4'-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicological Sciences, 58(2), 235-242.
DOI
|
13 |
J. J. Reiners Jr, R. Clift & P. Mathieu. (1999). Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor, Carcinogenesis, 20(2), 1561-1566.
DOI
|
14 |
H. Lee. (2017). The impact of o-toluidinyl structure of 2-me th yl -4 -(2 -met hyl p he nyl di az enyl ) p he nyl picolinamide on the AhR antagonistic activity, Journal of Korea Convergence Society, 8(1), 115-121.
DOI
|
15 |
I. Azumaya, T, Okamoto, F. Imabeppu & H. Takayanagi. (2003). Simple and convenient synthesis of teriary benzanilides using dichlorotriphenylphosphorane, Tetrahedron, 59(123), 2325-2331.
DOI
|